Selective cortical VGLUT1 increase as a marker for antidepressant activity
- 18 August 2005
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 49 (6) , 890-900
- https://doi.org/10.1016/j.neuropharm.2005.06.017
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Chronic Antidepressants Reduce Depolarization-Evoked Glutamate Release and Protein Interactions Favoring Formation of SNARE Complex in HippocampusJournal of Neuroscience, 2005
- Unmanageable Motivation in Addiction: A Pathology in Prefrontal-Accumbens Glutamate TransmissionPublished by Elsevier ,2005
- Clozapine‐, but not haloperidol‐, induced increases in ΔFosB‐like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptorsEuropean Journal of Neuroscience, 2004
- Increased Expression of theDrosophilaVesicular Glutamate Transporter Leads to Excess Glutamate Release and a Compensatory Decrease in Quantal ContentJournal of Neuroscience, 2004
- Vesicular Glutamate Transporters 1 and 2 Target to Functionally Distinct Synaptic Release SitesScience, 2004
- Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawalBehavioural Brain Research, 2003
- The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actionsBritish Journal of Pharmacology, 2003
- Muscarinic Receptor Function and Acetylcholinesterase Activity after Chronic Administration of Tacrine to Mice at Therapeutic Drug ConcentrationsPharmacology, 1992
- Lithium Treatment and Prophylaxis in Unipolar Depression: A Meta-analysisThe British Journal of Psychiatry, 1991
- Mechanisms of action of atypical antipsychotic drugs: Implications for novel therapeutic strategies for schizophreniaSchizophrenia Research, 1991